{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-218896","form_type":"8-K/A","ticker":"RMD","cik":"0000943819","company_name":"RESMED INC","filed_at":"2022-08-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:58.723783+00:00","generated_at":"2026-06-24T00:36:04.717906+00:00","sec_items":["8.01","1.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"medium","headline":"ResMed to acquire MediFox-Dan for EUR 810M; closing expected by Dec 31, 2022","bullets":["Base purchase price of EUR 810M fixed via locked box; enterprise value EUR 950M.","Funded with existing cash and borrowings under credit facility; intercompany loan to ResMed Germany SaaS.","Closing subject to German merger control, foreign investment, and BaFin clearances.","Termination fee of EUR 10M payable to seller if BaFin clearance not obtained.","Acquisition of 100% of MediFox-Dan shares and shareholder loan receivables."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-218896","json":"https://secwatch.observer/filing/0001193125-22-218896.json","markdown":"https://secwatch.observer/filing/0001193125-22-218896.md","text":"https://secwatch.observer/filing/0001193125-22-218896.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/943819/000119312522218896/0001193125-22-218896-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/943819/000119312522218896/d387047d8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T00:36:04.717906+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}